title: Point/counterpoint. Proton therapy is too expensive for the minimal potential improvements in outcome claimed.
authors.affiliation: Yale University, Johnson, Vermont 05656, USA. schulz@pshift.com
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Schulz
authors.forename: Alfred R
authors.initials: AR
authors.lastname: Smith
authors.forename: Colin G
authors.initials: CG
authors.lastname: Orton
mesh_terms: D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D009369:Neoplasms / Q000191:economics* / Q000532:radiotherapy*; D017063:Outcome Assessment, Health Care / Q000191:economics / Q000379:methods; D061766:Proton Therapy; D011882:Radiotherapy, High-Energy / Q000191:economics*; D014481:United States; D011522:Protons
chemical_list: D011522:Protons